{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:14:43Z","timestamp":1793330083228,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y2020024"],"award-info":[{"award-number":["Y2020024"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y20180159"],"award-info":[{"award-number":["Y20180159"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["ZS2017008"],"award-info":[{"award-number":["ZS2017008"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ19H080003"],"award-info":[{"award-number":["LQ19H080003"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY17H050005"],"award-info":[{"award-number":["LY17H050005"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ19H050002"],"award-info":[{"award-number":["LQ19H050002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["Y2020024"],"award-info":[{"award-number":["Y2020024"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["Y20180159"],"award-info":[{"award-number":["Y20180159"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007835","name":"Wenzhou Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772264"],"award-info":[{"award-number":["81772264"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31900685"],"award-info":[{"award-number":["31900685"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.intimp.2021.107374","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T22:50:35Z","timestamp":1611874235000},"page":"107374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-\u03b2\/Smad signaling"],"prefix":"10.1016","volume":"93","author":[{"given":"Yangping","family":"Shentu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shicheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanchang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shicheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rixu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaosheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongheng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenfei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2021.107374_b0005","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/jcmm.13393","article-title":"Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis","volume":"22","author":"Wu","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.intimp.2021.107374_b0010","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3389\/fphys.2018.01853","article-title":"Biocompatible peritoneal dialysis: the target is still way off","volume":"9","author":"Bartosova","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2021.107374_b0015","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/263285","article-title":"Are the mesothelial-to-mesenchymal transition, sclerotic peritonitis syndromes, and encapsulating peritoneal sclerosis part of the same process?","volume":"2013","author":"Loureiro","year":"2013","journal-title":"Int. J. Nephrol."},{"issue":"6","key":"10.1016\/j.intimp.2021.107374_b0020","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.kint.2016.01.025","article-title":"Protein kinase C alpha inhibition prevents peritoneal damage in a mouse model of chronic peritoneal exposure to high-glucose dialysate","volume":"89","author":"Wang","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2021.107374_b0025","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.biopha.2018.10.106","article-title":"SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2","volume":"109","author":"Zhou","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2021.107374_b0030","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ki.1993.36","article-title":"Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha","volume":"43","author":"Topley","year":"1993","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.intimp.2021.107374_b0035","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/(SICI)1097-0029(19971115)39:4<372::AID-JEMT7>3.0.CO;2-J","article-title":"Expression and potential role of the extracellular matrix in hepatic ontogenesis: a review","volume":"39","author":"Amenta","year":"1997","journal-title":"Microsc. Res. Tech."},{"issue":"3","key":"10.1016\/j.intimp.2021.107374_b0040","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.22721","article-title":"Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development","volume":"49","author":"Asahina","year":"2009","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2021.107374_b0045","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1177\/089686080902902S28","article-title":"Insulin resistance and glucose homeostasis in peritoneal dialysis","volume":"29","author":"Fortes","year":"2009","journal-title":"Perit. Dial. Int."},{"issue":"12","key":"10.1016\/j.intimp.2021.107374_b0050","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1093\/ndt\/gfr217","article-title":"Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of Toll-like receptors","volume":"26","author":"Colmont","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2021.107374_b0055","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1177\/089686080702702s13","article-title":"In vitro study of peritoneal fibrosis","volume":"27","author":"Hung","year":"2007","journal-title":"Perit. Dial. Int."},{"issue":"7","key":"10.1016\/j.intimp.2021.107374_b0060","doi-asserted-by":"crossref","first-page":"12959","DOI":"10.3390\/ijms150712959","article-title":"Astragalus membranaceus inhibits peritoneal fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-beta1 (TGF-beta1) pathway in rats submitted to peritoneal dialysis","volume":"15","author":"Li","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2021.107374_b0065","first-page":"1030","article-title":"MicroRNA-21 promotes the progression of peritoneal fibrosis through the activation of the TGF-beta\/Smad signaling pathway: an in vitro and in vivo study","volume":"41","author":"Ma","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.intimp.2021.107374_b0070","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/clpt.2008.250","article-title":"Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus","volume":"85","author":"Komoroski","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2021.107374_b0075","doi-asserted-by":"crossref","first-page":"890","DOI":"10.2337\/db10-1328","article-title":"SGLT2 deletion improves glucose homeostasis and preserves pancreatic beta-cell function","volume":"60","author":"Jurczak","year":"2011","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.intimp.2021.107374_b0080","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/dom.12073","article-title":"Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes","volume":"15","author":"Heise","year":"2013","journal-title":"Diabetes Obes. Metab."},{"issue":"5","key":"10.1016\/j.intimp.2021.107374_b0085","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/CIRCULATIONAHA.113.005081","article-title":"Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus","volume":"129","author":"Cherney","year":"2014","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.intimp.2021.107374_b0090","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/1060028017710481","article-title":"SGLT-2 inhibitors: is there a role in Type 1 diabetes mellitus management?","volume":"51","author":"Ahmed-Sarwar","year":"2017","journal-title":"Ann. Pharmacother."},{"issue":"3","key":"10.1016\/j.intimp.2021.107374_b0095","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.kint.2018.05.002","article-title":"A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor-dependent pathway after renal injury in mice","volume":"94","author":"Zhang","year":"2018","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.intimp.2021.107374_b0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.33594\/000000003","article-title":"Effects of the SGLT-2 inhibitor canagliflozin on adenine-induced chronic kidney disease in rats","volume":"52","author":"Ali","year":"2019","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.intimp.2021.107374_b0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12933-019-0816-2","article-title":"SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart","volume":"18","author":"Li","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107374_b0110","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4239\/wjd.v10.i2.114","article-title":"SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: a systematic review","volume":"10","author":"Raj","year":"2019","journal-title":"World J. Diabetes"},{"issue":"2","key":"10.1016\/j.intimp.2021.107374_b0115","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/ki.2013.81","article-title":"Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-beta1 signaling","volume":"84","author":"Ueno","year":"2013","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.intimp.2021.107374_b0120","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ndt\/gft397","article-title":"Paracrine effects of transplanted mesothelial cells isolated from temperature-sensitive SV40 large T-antigen gene transgenic rats during peritoneal repair","volume":"29","author":"Kanda","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.intimp.2021.107374_b0125","first-page":"321","article-title":"Culture and characterization of human peritoneal mesothelial cells","volume":"26","author":"Liu","year":"2001","journal-title":"Hunan Yi Ke Da Xue Xue Bao"},{"issue":"6","key":"10.1016\/j.intimp.2021.107374_b0130","first-page":"841","article-title":"Identification of endothelial and mesothelial cells in human omental tissue and in omentum-derived cultured cells by specific cell markers","volume":"63","author":"Potzsch","year":"1990","journal-title":"Lab. Invest."},{"issue":"4","key":"10.1016\/j.intimp.2021.107374_b0135","first-page":"274","article-title":"Experience in primary culture of human peritoneal mesothelial cell","volume":"55","author":"Chen","year":"2012","journal-title":"Chin. J. Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107374_b0140","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/path.1711450204","article-title":"Mesothelial healing: morphological and kinetic investigations","volume":"145","author":"Whitaker","year":"1985","journal-title":"J. Pathol."},{"issue":"Pt 7","key":"10.1016\/j.intimp.2021.107374_b0145","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1242\/jcs.115.7.1383","article-title":"Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing","volume":"115","author":"Foley-Comer","year":"2002","journal-title":"J. Cell Sci."},{"issue":"6","key":"10.1016\/j.intimp.2021.107374_b0150","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1177\/039139880703000606","article-title":"The origin of regenerating mesothelium: a historical perspective","volume":"30","author":"Mutsaers","year":"2007","journal-title":"Int. J. Artif. Organs"},{"key":"10.1016\/j.intimp.2021.107374_b0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1242\/jcs.85.1.133","article-title":"Adhesion, growth and morphology of human mesothelial cells on extracellular matrix","volume":"85","author":"Niedbala","year":"1986","journal-title":"J. Cell Sci."},{"issue":"3","key":"10.1016\/j.intimp.2021.107374_b0160","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/00365519850186580","article-title":"Characterization and fibrinolytic properties of mesothelial cells isolated from peritoneal lavage","volume":"58","author":"Ivarsson","year":"1998","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"5","key":"10.1016\/j.intimp.2021.107374_b0165","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/ndt\/14.5.1208","article-title":"Epidermal growth factor modifies the expression and function of extracellular matrix adhesion receptors expressed by peritoneal mesothelial cells from patients on CAPD","volume":"14","author":"Leavesley","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.intimp.2021.107374_b0170","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa020809","article-title":"Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells","volume":"348","author":"Yanez-Mo","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.intimp.2021.107374_b0175","doi-asserted-by":"crossref","first-page":"F449","DOI":"10.1152\/ajprenal.00431.2018","article-title":"Unraveling reno-protective effects of SGLT2 inhibition in human proximal tubular cells","volume":"316","author":"Pirklbauer","year":"2019","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"12","key":"10.1016\/j.intimp.2021.107374_b0180","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00535-016-1200-6","article-title":"Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long-Evans Tokushima fatty rats","volume":"51","author":"Nishimura","year":"2016","journal-title":"J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.intimp.2021.107374_b0185","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1536\/ihj.18-392","article-title":"Inhibitory effects of tofogliflozin on cardiac hypertrophy in dahl salt-sensitive and salt-resistant rats fed a high-fat diet","volume":"60","author":"Kimura","year":"2019","journal-title":"Int. Heart J."},{"issue":"1","key":"10.1016\/j.intimp.2021.107374_b0190","doi-asserted-by":"crossref","first-page":"20180103","DOI":"10.1515\/pp-2018-0103","article-title":"Hypoxia, cytokines and stromal recruitment: parallels between pathophysiology of encapsulating peritoneal sclerosis, endometriosis and peritoneal metastasis","volume":"3","author":"Wilson","year":"2018","journal-title":"Pleura Peritoneum"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921000102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921000102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:54:31Z","timestamp":1778619271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921000102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":38,"alternative-id":["S1567576921000102"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107374","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-\u03b2\/Smad signaling","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107374","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107374"}}